Results

Total Results: 1,112 records

Showing results for "phase".

1061. Assessing-The-Risk-Of-Bias-In-Systematic-Reviews-Of-Health-Care-Interventions (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01.pdf
      May 01, 2005 - the extent or comprehensiveness of reporting.a Reporting the Risk of Bias During the protocol phase

1062. Ced-Topic-Refinement (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
      November 01, 2022 - In response, the requirement was modified to reflect that existing evidence (such as from phase II

1063. Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
      April 01, 2013 - raise actually relates to analytic follow- up of an observation made during the early data analysis phase

1064. Comparative Effectiveness and Safety of Analgesics for Osteoarthritis—An Update of the 2006 Report. (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
      October 01, 2011 - receive either 800 mg chondroitin sulfate or placebo once daily for 6 months followed by an open-label phase

1065. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository Evidence Base (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/ptsd-3-draft-report.pdf
      January 12, 2022 - since we will not complete updated RoB assessment for all 389 studies from the previous report in this phase

1066. Appendices A-E (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/healthcare-system-appendixes-draft-technical-brief.pdf
      February 01, 2023 - Asthma-Related Outcomes Among Children Participating in the Head-Off Environmental Asthma in Louisiana (HEAL), Phase

1067. Urinary-Incontinence-Treatment Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
      October 29, 2012 - Phase  IIb,  multicenter,  double-­‐blind,   randomized,  placebo-­‐controlled,   parallel

1068. GRADING THE STRENGTH OF A BODY OF EVIDENCE (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-evidence_methods.pdf
      November 01, 2013 - these choices considering the input of key informants, including patients, during the topic refinement phase

1069. Evaluating Practices and Developing Tools for Comparative Effectiveness Reviews of Diagnostic Test Accuracy: Methods for the Joint Meta-Analysis of Multiple Tests (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/diagnostic-tests-accuracy_research.pdf
      January 01, 2013 - Evaluating Practices and Developing Tools for Comparative Effectiveness Reviews of Diagnostic Test Accuracy: Methods for the Joint Meta-Analysis of Multiple Tests ! ! Methods Research Report Evaluating Practices and Developing Tools for Comparative Effectiveness Reviews of Diagnostic Test Accuracy: Met…

1070. Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults. (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
      February 01, 2012 - Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults. Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=971 Published Online: February 2012 Comparative Effectiveness Re…

1071. Technical Brief 13: Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
      December 01, 2012 - Technical Brief 13: Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer Technical Brief Number 13 Technical Brief Number 13 Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer …

1072. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
      April 01, 2011 - Takeda has completed a phase 1, randomized, open-label, 2 period, crossover study to evaluate the effect … release (MR) - The objective of the study was to assess the safety of dexlansoprazole MR from the phase … Pediatric patients - Dexlansoprazole is not FDA approved for use in patients less than 18 years of age.1A phase … dexlansoprazole in adolescents 12-17 years of age with symptomatic GERD has been completed.8 A second phase

1073. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
      March 16, 2017 - not all effects are likely to become evident in all patients within the one-to-two month treatment phase … own “across study” subgroup analyses using study-level data on our variables of interest (e.g., phase … We are happy our interpretations were correct for the controlled phase. … Thank you for sharing the results from the open label phase, although this does not meet our inclusion

1074. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
      March 16, 2017 - not all effects are likely to become evident in all patients within the one-to-two month treatment phase … own “across study” subgroup analyses using study-level data on our variables of interest (e.g., phase … We are happy our interpretations were correct for the controlled phase. … Thank you for sharing the results from the open label phase, although this does not meet our inclusion

1075. Juvenile-Arthritis-Dmards Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
      March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections

1076. Juvenile-Arthritis-Dmards Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
      March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections

1077. McCormack-notes-151008 copy - Teresa (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/mccormack-presentation.pdf
      November 12, 2015 - McCormack-notes-151008 copy - Teresa My talk today is about engaging patients with  low health  literacy. 1 Health literacy is a key factor in securing access to healthcare services. So in my talk today, I’ll talk a little bit about health literacy and what it is, how we measure health literacy and the sta…

1078. Schwitzer_ECCS2012 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
      July 23, 2012 - Schwitzer_ECCS2012 Slide 1: Addressing  Tensions  When Popular Media and Evidence-­‐Based Care Collide Gary  Schwitzer Publisher,  HealthNewsReview.org Slide 2: Infoxication We are drowning people who are thirsty for just a sip of balanced infor…

1079. Disposition of Comments Report for Comparative Effectiveness Review No. 137 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_disposition-comments.pdf
      August 06, 2014 - Behavioral Health and Wellness) General Are there any identifiable changes early in the treatment phase … Health and Wellness) General What is the evidence that effects measured at the end of the treatment phase

1080. #06 Developmental Delays ADHD, and Autism (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
      January 01, 2012 - inclusion are those interventions expected to be within 0 to 4 years of potential diffusion (e.g., in phase … III trials for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … Results The table below lists the six topics for which (1) preliminary phase III data were available … Currently interventions such as this humanoid robotic doll are in an early phase of development and